Torsade de pointes following intravenous haloperidol administration in a patient with complete heart block
Mahazarin Ginwalla1, Lee Arnold Biblo, Hakan Paydak
1Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, Wis., USA.
Abstract:
Torsade de pointes (TdP) due to QT prolongation is often a drug-induced ventricular tachyarrhythmia. Different classes of drugs including antiarrhythmics, antipsychotics, and antimicrobials may lead to TdP by a patient-specific response altering repolarization. Combinations of other TdP risk factors such as bradycardia, ischemia, or electrolyte abnormalities are usually also present. In this paper, we describe the development of TdP after the administration of intravenous haloperidol in a patient with complete heart block. The importance of evaluating predisposing risk factors before the administration of any potential QT-prolonging medications is highlighted.
Related Concept Videos
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Dysrhythmias IV: Characteristics of Bradyarrhythmias
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias VI: Management of Dysrhythmias


